OHSU turns innovations into commercial opportunities at r...(s to establish. The National Institutes ...)

Date:10/23/2007

s to establish. The National Institutes of Health, which allocates more than $4 billion annually toward infectious disease research, funds strong infectious disease research programs at Oregons research universities. The company will work closely with the universities to turn discoveries into products that improve peoples health. [ For more information about ID Biopharma, go to http://www.idbiopharma.com ]

• Yecuris, Inc. plans to launch products that will use novel technologies to address the problem of liver toxicity, one of the primary obstacles to safe and efficient drug development. When new drug compounds are being developed they need to be tested on human liver cells to predict how the human liver will metabolize it. One in six compounds fail in the development stage because of liver toxicity. The market demand for such cells has reached an estimated $2 billion a year worldwide, but the supply is spotty. The company founded by Markus Grompe, M.D., professor of molecular and medical genetics, and pediatrics, OHSU School of Medicine, and director of the Oregon Stem Cell Center anticipates providing an economical and reliable source of these cells based on a technology that, in essence, turns a mouse into a factory for human liver cells. [ See OHSU press release: http://www.ohsu.edu/ohsuedu/newspub/releases/livercells080907.cfm ]

• Cylerus a company founded by Stephen Hanson, Ph.D., head of the OHSU Department of Biomedical Engineering is developing technological improvements that will enable uniform, localized drug delivery for preserving the functions of artificial blood vessels (vascular grafts). These advances will address the unmet medical need to prevent vascular graft failure that currently results from localized blood clotting and abnormal tissue ingrowth within such grafts. The co
  '/>"/>

Contact: Harry Lenhart lenharth@ohsu.edu 503-494-8231 Oregon Health & Science University Source:Eurekalert

1 GOOD

Page: 1 2 3 4 5
Related biology news :

1. Lack of enzyme turns fat cells into fat burners
2. Programmable cells: Engineer turns bacteria into living computers
3. Gene therapy turns off mutation linked to Parkinsons disease
4. Hopkins researchers discover genetic switch that turns off an oxygen-poor cells combustion engine
5. Jefferson researchers uncover new way nature turns genes on and off
6. Leukemia drug turns mini-molecules up, cancer genes down
7. Agilent Technologies releases probe sequence, annotation information for all its commercial gene expression microarrays
8. Why were the HIV prevention trials in commercial sex workers abandoned?
9. Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research
10. Hopkins study suggests commercially available antibiotic may help fight dementia in HIV patients
11. Commercial fishing causes dangerous fluctuations in fish populations